Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, Aboulfoutouh I, Khattab SM, van Wely M. Youssef MA, et al. Among authors: griesinger g. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008046. doi: 10.1002/14651858.CD008046.pub3. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2014 Oct 31;(10):CD008046. doi: 10.1002/14651858.CD008046.pub4 PMID: 21249699 Updated. Review.
Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, Ejdrup Bredkjaer H, Humaidan P. Griesinger G, et al. Fertil Steril. 2007 Sep;88(3):616-21. doi: 10.1016/j.fertnstert.2006.12.006. Epub 2007 Apr 23. Fertil Steril. 2007. PMID: 17451691 Free article.
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
Youssef MA, Van der Veen F, Al-Inany HG, Griesinger G, Mochtar MH, van Wely M. Youssef MA, et al. Among authors: griesinger g. Cochrane Database Syst Rev. 2010 Nov 10;(11):CD008046. doi: 10.1002/14651858.CD008046.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2011 Jan 19;(1):CD008046. doi: 10.1002/14651858.CD008046.pub3 PMID: 21069701 Updated. Review.
Emerging gonadotropin-releasing hormone agonists.
Beyer DA, Amari F, Thill M, Schultze-Mosgau A, Al-Hasani S, Diedrich K, Griesinger G. Beyer DA, et al. Among authors: griesinger g. Expert Opin Emerg Drugs. 2011 Jun;16(2):323-40. doi: 10.1517/14728214.2010.547472. Epub 2011 Jan 19. Expert Opin Emerg Drugs. 2011. PMID: 21244327 Review.
Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S. Griesinger G, et al. Fertil Steril. 2011 May;95(6):2029-33, 2033.e1. doi: 10.1016/j.fertnstert.2011.01.163. Epub 2011 Mar 2. Fertil Steril. 2011. PMID: 21371705 Clinical Trial.
166 results